Norges Bank Instil Bio, Inc. Transaction History

Norges Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$8.48 - $18.1 $127,200 - $271,500	-15,000 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$15.37 - $22.5 $230,550 - $337,500	15,000 New	15,000 $257,000
Q3 2021 Nov 14, 2022	BUY	$15.05 - $23.28 $225,750 - $349,200	15,000 New	15,000 $268,000
Q3 2021 Nov 05, 2021	SELL	$15.05 - $23.28 $225,750 - $349,200	-15,000 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$15.31 - $24.63 $229,650 - $369,450	15,000 New	15,000 $290,000
Q2 2021 Aug 10, 2021	SELL	$15.31 - $24.63 $229,650 - $369,450	-15,000 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$24.23 - $27.06 $363,450 - $405,900	15,000 New	15,000 $376,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.82B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.